J-Pharma Co (TSE:520A) Net Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Net Margin %?

J-Pharma Co TSE:520A -2.36% 9 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100. Among 941 Biotechnology companies, J-Pharma Co ranks worse than 106269.82% on this metric.

Net margin is calculated as Net Income divided by its Revenue. J-Pharma Co's Net Income for the three months ended in Dec. 2025 was 円-447.93 Mil. J-Pharma Co's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, J-Pharma Co's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for J-Pharma Co's Net Margin % or its related term are showing as below:


TSE:520A's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.29
* Ranked among companies with meaningful Net Margin % only.

J-Pharma Co  (TSE:520A) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

J-Pharma Co Net Margin % Related Terms

J-Pharma Co Net Margin % Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Net Margin % Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Net Margin %
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Net Margin % 0.00 0.00 0.00

TSE:520A vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, J-Pharma Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J-Pharma Co Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, J-Pharma Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where J-Pharma Co's Net Margin % falls into.


TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

J-Pharma Co's Net Margin for the fiscal year that ended in Mar. 2025 is calculated as

Net Margin=Net Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-1499.008/0
= %

J-Pharma Co's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-447.927/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
J-Pharma Co (TSE:520A) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on J-Pharma Co and its competitors. According to the industry distribution chart, J-Pharma Co ranks #999999 out of 941 companies in the Biotechnology industry.
Is J-Pharma Co's Net Margin % too high?
J-Pharma Co's current Net Margin % is 0.00%. Based on the distribution chart, J-Pharma Co ranks #999999 out of 941 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, J-Pharma Co ranks #999999 out of 941 companies for Net Margin %. This places J-Pharma Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price